Mergers & Acquisitions - Pharmaceutical, Research


Current filters:


Popular Filters

1 to 25 of 46 results

AstraZeneca stresses confidence in independence, highlighting strong R&D pipeline


Anglo-Swedish pharma major AstraZeneca, the subject of the controversial takeover attempt by Pfizer,…

AstraZenecaCardio-vascularMergers & AcquisitionsMetabolicsOncologyPharmaceuticalResearchRespiratory and Pulmonary

AstraZeneca sets out its value stall, projecting annual revenues of $45 billion by 2023

AstraZeneca sets out its value stall, projecting annual revenues of $45 billion by 2023


In a bid to explain its rejection of US pharma giant Pfizer’s increased takeover bid for the Anglo-Swedish…

AstraZenecaFinancialMergers & AcquisitionsPfizerPharmaceuticalResearch

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators


Confirming strong rumors over the past week or so, German pharma major Bayer confirmed it has agreed…

AdempasBayerLicensingMerck & CoMergers & AcquisitionsPharmaceuticalResearchRespiratory and Pulmonaryvericiguat

Perrigo transfers ELND005 assets; buys OTC products


Drugmaker Perrigo has entered into a series of agreements with existing collaboration partner, Transition…

ELND005Mergers & AcquisitionsNeurologicalPerrigoPharmaceuticalResearchTransition Therapeutics

Prothelia and Alexion partner with University of Nevada for ultra-rare neuromuscular disorder

Prothelia and Alexion partner with University of Nevada for ultra-rare neuromuscular disorder


Privately-held USA-based Prothelia and the University of Nevada, Reno, have entered into strategic agreements…

Alexion PharmaceuticalsMergers & AcquisitionsPharmaceuticalProtheliaRare diseasesResearch

Moderna spins-out Onkaido Therapeutics to focus on mRNA therapeutics in oncology


Flush with cash as a result of its mega-million dollar deal with Alexion on the development of drugs…

Mergers & AcquisitionsModerna TherapeuticsOncologyOnkaido TherapeuticsPharmaceuticalResearch

NeXeption forms new company, Alexar Therapeutics, to develop novel LXR agonist portfolio


US biopharma management company NeXeption says it has secured $21.5 million in Series A financing to…

A-110Alexar TherapeuticsDermatologicalsFinancialMergers & AcquisitionsNeXeptionPharmaceuticalResearch

Astellas links with Mitokyne on mitochondria-related therapies

Astellas links with Mitokyne on mitochondria-related therapies


Japanese drug major Astellas Pharma and USA-based start-up Mitokyne have entered into an exclusive R&D…

Astellas PharmaFinancialLicensingMergers & AcquisitionsMitokynePharmaceuticalResearch

Briefs: Depomed drops Sefelsa after CRL: Sun Pharma stalking Meda?


US specialty drugmaker Depomed (Nasdaq: DEPO) says that Food and Drug Administration issued a complete…

DepomedMedaMergers & AcquisitionsMetabolicsNorth AmericaPharmaceuticalRegulationResearchSefelsaSun Pharmaceutical Industries

Briefs: Royalty sweetens offer for Elan; AstraZeneca biomarker deal


US private equity company Royalty Pharma today (April 15) issued a firm improved takeover offer for Ireland-based…

AstraZenecaElanLicensingMergers & AcquisitionsOncologyOxford Cancer BiomarkersPharmaceuticalResearchRoyalty Pharma

AstraZeneca acquires AlphaCore; Merck Serono links with BioMed X


In line with its stated policy of targeted acquisitions, Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AlphaCore PharmaAstraZenecaBiotechnologyCardio-vascularMerck KGaAMerck SeronoMergers & AcquisitionsMetabolicsPharmaceuticalResearch

Phytopharm views options, including merger, as Cogane fails


UK-based Phytopharm (LSE: PYM: London Stock Exchange), ahead of its annual general meeting today (March…

CoganeMergers & AcquisitionsNeurologicalPharmaceuticalPhytopharmResearch

Sorrento Therapeutics signs exclusive option to acquire IGDRASOL


USA-based Sorrento Therapeutics, Inc. (SRNE: OB) has signed an exclusive option to acquire IGDRASOL,…

IGDRASOLMergers & AcquisitionsOncologyPharmaceuticalResearchSorrento Therapeutics

GlaxoSmithKline and Biological E set up JV to develop combination vaccine


UK pharma giant GlaxoSmithKline (LSE: GSK) and Indian vaccines company Biological E have entered into…

Asia-PacificBiological E LtdGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalResearchVaccines

DelMar Pharma acquisition; $5.4 million private placement to advance novel cancer therapies


DelMar Pharmaceuticals (OTCQB: BRRY) has announced the successful acquisition, through a share exchange…

DelMar PharmaceuticalsFinancialMergers & AcquisitionsOncologyPharmaceuticalResearchVAL-083

Teijin collaborates with InCube Labs to boost health care business


Japan's Teijin (TYO: 3401) says it has signed a strategic partnership agreement with InCube Labs, a California-based…

InCube LabsMergers & AcquisitionsPharmaceuticalResearchTeijin

Illumina to buy Verinata; Rusnano et al invest in Marinus


USA-based Illumina (Nasdaq: ILMN), recently the subject of a failed takeover bid by Swiss drug major…

Domain AssociatesFinancialganaxoloneIlluminaMarinus PharmaceuticalsMergers & AcquisitionsNeurologicalPharmaceuticalResearchRusNanoVerinata Health

Japan Pharma: Expectations for 2013, by P Reed Maurer


The biggest non-event in the Japan health care market during 2013 will be no reimbursement price reductions,…

Asia-PacificGenericsLicensingMergers & AcquisitionsPharmaceuticalPricingResearch

WuXi PharmaTech sets up clinical trials JV with PRA


Chinese contract research organization WuXi PharmaTech (NYSE: WX) and PRA, a global clinical CRO, have…

Asia-PacificMergers & AcquisitionsPharmaceuticalResearchWuXi PharmaTech

MicuRx joins forces with VC for next-generation antibiotic for China


MicuRx Pharmaceuticals, a privately-held US biopharmaceutical company developing next-generation antibiotics,…

Antibiotics and Infectious diseasesAsia-PacificMergers & AcquisitionsMicuRx PharmaceuticalsMRX-IPharmaceuticalResearchShanghai MengKe Pharma

Almirall expands in personalized medicine with 5% equity stake in AB-Biotics


Spain's largest pharma company Almirall (ALM.MC) says it has reached an agreement with the Spanish biotech…

AB-BioticsAlmirallBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

1 to 25 of 46 results

Back to top